Connolly Bove Lodge & Hutz LLP has made room for a new partner and two of counsels as part of the budding intellectual property practice in its Los Angeles office.
A law firm and a financial advisor that served in the Chapter 11 proceedings of J.L. French Automotive Castings Inc. are seeking final compensation for services performed during the auto parts company’s restructuring.
The legal landscape may look bleak for Rambus Inc. after the U.S. Federal Trade Commission’s recent antitrust ruling against the technology-licensing company, but Rambus is confident the decision isn’t a death-knell for its related cases.
Semiconductor developer AmberWave Systems Corp. has fired off a fresh patent infringement lawsuit against Intel Corp. in response to Intel’s declaratory relief action last month claiming it did not violate an AmberWave patent covering semiconductor device fabrication.
Alcatel SA, the French telecommunications giant, duped a global standard-setting body into adopting industrywide standards without disclosing that it held patent applications for the technology, according to a federal antitrust lawsuit filed this week.
A federal bankruptcy judge has disallowed 53 asbestos-related property damage claims against W.R. Grace & Co. Inc. But Grace still faces a slew of claims, and a criminal case.
An appeals court handed Pfizer Inc. a mixed ruling Wednesday, affirming a lower court’s decision that a patent covering Pfizer’s blockbuster drug Lipitor was valid, but striking down a second Lipitor-related Pfizer patent on technical grounds.
Hoping to block its rival from getting a leg up in the lucrative insulin market, drug maker Novo Nordisk A/S has smacked Pfizer Inc. with an infringement suit, claiming that its inhalable insulin product Exubera tramples upon the Danish company’s patents.
Natural gas provider El Paso Corporation has agreed to pay $273 million to settle a shareholder class action alleging securities fraud and the manipulation of markets.
A bankruptcy judge has signed off on a deal that will allow biopharmaceutical company Aphton Corp. to sell off its gastrointestinal cancer drug to Receptor BioLogix Inc.
The U.S. Securities and Exchange Commission has accused three former executives of Janus Capital Management LLC of violating securities laws by engaging in alleged improper market-timing and frequent trading of certain mutual funds.
Chunghwa Picture Tubes Ltd. announced Friday that it will appeal a jury decision to award LG Philips LCD Co. $52.5 million for patent infringement.
Digene Corp., a manufacturer of genetic-testing products, said Monday that an arbitration panel found that a rival breached a cross-licensing agreement covering the sale of its human papillomavirus (HPV) business.
When a Chapter 11 debtor seeks to void multiple pension plans at the same time under its reorganization test, a court can apply one test to all of the plans, according to a ruling filed last week in the U.S. District Court of Appeals for the Third Circuit.
Boston Scientific Corp. and St. Jude Medical Inc. have settled four federal patent infringement cases and an arbitration proceeding, and have struck a deal on the parameters for litigating two ongoing cases.
Pfizer Inc.’s surprise decision to replace its chief executive with its general counsel highlights the increasingly important role played by top lawyers in the health-care industry, observers say.
A Delaware bankruptcy judge has authorized $2.4 billion in exit financing to Owens Corning, with Citigroup Global Markets Inc. and Bank of America NA serving as joint lead arrangers.
A bankruptcy judge has signed off on Meridian Automotive Systems Inc.’s third amended disclosure statement, clearing the way for the auto parts maker to offer up the plan to creditors for a vote.
A week after filing a lawsuit against the company’s former executives, the U.S. Trustee for bankrupt mortgage lender American Business Financial Services Inc. has objected to a request by former company leaders for additional money for their legal expenses.
Bankrupt hedge fund manager PlusFunds Group Inc. has sued Standard & Poor’s, alleging the popular financial data publisher breached a license agreement when it axed its hedge fund index that was stocked with PlusFunds’ data.